Live tape
Top 8, mentions 7d11,644SPCX2,374 mentions▲ +0.08TSLA1,898 mentions▲ +0.05META1,822 mentions▲ +0.04GOOGL1,751 mentions▲ +0.02NFLX1,031 mentions▲ +0.03QQQ978 mentions▲ +0.05NVDA927 mentions▲ +0.07AMZN863 mentions▲ +0.06

Equity · Healthcare

ALNY

NASDAQ

Alnylam Pharmaceuticals (ALNY)

$227.35 +1.04% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 22, 2026

Reddit mentioned ALNY 5 times in the 30 days to 23 October 2026, in 1 of the communities we track. All of them were scored for sentiment: 80% read bullish, 0% bearish and 20% neither. Reddit data updated 23 October 2026.

Price · Chart
63 sessions
$300 $200 27 Jul 22 Oct

The line runs $278 on 27 July through $227.35 on 22 October, on a scale from $200 to $300. Days the market did not trade hold the previous close, flat.

Market cap $30.4B
P/E (TTM) 97.6
52-week range $203 – $491
Avg volume 87.7K
Mentions · 30d 5
Net sentiment +0.13

as of Oct 22, 2026

Alnylam Pharmaceuticals (ALNY) · crowd attention × price

Share ↗
5 mentions

Day30 Sep 2026

MENTIONS20–4 / day
PRICE$246.69$200–$260
ALNY over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day01234usd$200$220$240$26024 Sep1 Oct9 Oct16 Oct23 Oct
ALNY over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.24 Sep9 Oct23 Oct
The Distributed Sentinel 23 Oct 2026

ALNY drew 5 Reddit mentions over the 30 days to 23 October 2026

This chart in words

The chart plots daily Reddit mentions of ALNY over the 30 days to 23 October 2026: 5 in total, busiest on 29 September with 3, and 2 on the last day counted. The line is the daily close over the same window: $250 on 24 September, $227.35 on 22 October. Of those days, 21 were trading sessions and the other 9 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Alnylam Pharmaceuticals (ALNY) on Reddit · 30d

n = 5 scored · Method

In the 30 days to 23 Oct 2026, Alnylam Pharmaceuticals drew 5 Reddit mentions in the finance subreddits we track, 5 of them scored for sentiment.

ALNY

80% bullish

Overall market sentiment

54% bullish

ALNY reads 26 points more bullish than overall market sentiment. Same measure; same 30-day window.

Where ALNY is discussed

(30d)
r/wallstreetbets 100% 5 +0.13

Alnylam Pharmaceuticals (ALNY) insider trades

SEC Form 4 · last 90 days · newest reported trade 2 Oct 2026

In the 90 days to 23 Oct 2026, Alnylam Pharmaceuticals insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 2 Mar 2026, show no open-market purchase.

Open-market buys 0
Open-market sells 1
Net sold $399K
Non-trade filings 1
Date Insider Type Shares Value
02 Oct 2026 SUPRAN BRYAN EVP, CLO and Secretary Sell 1,758 $399K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
19 Sep 2026 Greenstreet Yvonne Chief Executive Officer Award 107

Alnylam Pharmaceuticals (ALNY) reported financials

SEC EDGAR XBRL SEC EDGAR

Alnylam Pharmaceuticals reported revenue of $3.7B for the fiscal year ended 31 Dec 2025. Net income over the same period was $313.7M.

Figure Reported Period
Revenue $3.7B 31 Dec 2025 fiscal year
Net income $313.7M 31 Dec 2025 fiscal year
Diluted EPS $2.33 31 Dec 2025 fiscal year
Total assets $5.6B 30 Jun 2026 at period end
Total equity $1.4B 30 Jun 2026 at period end

Alnylam Pharmaceuticals (ALNY) earnings

SEC EDGAR

Alnylam Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $1.21; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 $1.21 —
31 Dec 2025 FY 2025 $2.33 —
30 Sep 2025 FY 2025 $1.51 —
30 Jun 2025 FY 2025 −$0.70 —
31 Mar 2025 FY 2025 −$0.14 —
31 Dec 2024 FY 2024 −$2.18 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Alnylam Pharmaceuticals (ALNY) institutional holders (13F)

SEC Form 13F SEC EDGAR

10 of the 45 institutional funds we track reported a Alnylam Pharmaceuticals position for the quarter ended 30 Jun 2026 — a combined $1.5B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Two Sigma Investments Held (±25%) −5.9% shares 1,875,937 $564.7M
D. E. Shaw & Co. Held (±25%) +4.3% shares 1,104,109 $332.4M
AQR Capital Management Held (±25%) −20.3% shares 728,039 $219.0M
Millennium Management Trimmed −29.4% shares 316,001 $95.1M
Marshall Wace Trimmed −76.4% shares 259,799 $78.2M
Citadel Advisors Added +715.8% shares 191,029 $57.5M
Man Group Trimmed −26.5% shares 170,907 $51.4M
Bridgewater Associates Held (±25%) −6.6% shares 99,584 $30.0M
Balyasny Asset Management New position 89,510 $26.9M
Fisher Asset Management Held (±25%) +3.4% shares 6,252 $1.9M

Alnylam Pharmaceuticals (ALNY) fails-to-deliver

SEC CNS data SEC

On 24 Sep 2026, 1,112 shares of Alnylam Pharmaceuticals failed to deliver (about $274K) — the latest of 4 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
24 Sep 2026 1,112 $274K 0.001%
23 Sep 2026 1,116 $281K 0.001%
22 Sep 2026 1,379 $337K 0.001%
21 Sep 2026 100 $24K <0.001%
15 Sep 2026 159 $40K <0.001%

Congressional trades in Alnylam Pharmaceuticals (ALNY)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Alnylam Pharmaceuticals is a sale by Jefferson Shreve (house, IN), dated 12 May 2025.

Date Member Type Amount
12 May 2025 filed 22 Jun 2025 Jefferson Shreve house · Republican–IN Sale $15K–$50K
29 Jan 2024 filed 15 Feb 2024 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
11 Jan 2024 filed 15 Feb 2024 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
11 Dec 2023 filed 07 Jan 2024 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
06 Mar 2023 filed 17 Apr 2023 Daniel S. Goldman house · Democrat–NY Purchase $15K–$50K
28 Sep 2022 filed 16 Oct 2022 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
13 Nov 2020 filed 09 Dec 2020 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K

Alnylam Pharmaceuticals (ALNY): frequently asked questions

From live data

Have Alnylam Pharmaceuticals insiders bought or sold shares recently?

In the 90 days to 23 Oct 2026, Alnylam Pharmaceuticals insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 2 Mar 2026, show no open-market purchase. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade.

How many institutions hold Alnylam Pharmaceuticals?

10 of the 45 institutional funds we track reported a Alnylam Pharmaceuticals position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Alnylam Pharmaceuticals had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Alnylam Pharmaceuticals is dated 24 Sep 2026, when 1,112 shares failed to deliver.

When did Alnylam Pharmaceuticals last report earnings?

Alnylam Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $1.21; no next date is announced in SEC filings yet.

What exchange is Alnylam Pharmaceuticals listed on?

Alnylam Pharmaceuticals trades on NASDAQ under the ticker ALNY.

What is Reddit saying about Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals was mentioned 0 times in the last 7 days across the finance subreddits we track, and 5 times over the trailing 30 days. Of 5 classified mentions, 80% read bullish, 0% bearish and 20% neutral. Crowd sentiment is a social signal, not investment advice.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SEC EDGARValuation computed from SEC EDGAR filings